Chuck,
TCPI specializes in developing, mft, and marketing point-of-care medical products. They already have products on the market, producing revenue, including their Health Check (TM) line, which is a comprehensive line of home health screening and monitoring products. This includes a urine test for UTI's, a urine test for glucose, a home cholesterol test, home pregnancy tests, and others. This link concerns the rollout:
biz.yahoo.com
Their current product line provides a foundation, but, the product that could make this a very pofitable investment is the noninvasive blood glucose system:
biz.yahoo.com
If this system hits the market ahead of their competition, this stock could shoot to $40 (no hype). As far as I can tell, TCPI is much closer to bringing their product to the market than anyone else. They are the only company that I know of that currently has a working system. As the above link indicates, they are starting clinical trials, which, we all hope, will lead to rapid FDA approval.
Zach's rating is 1.5, a healthy buy. It ranks 36/108 in their
industry (Med Products). Consensus earnings estimate for 1998 is 1.09, compared to -0.45 this year. There are only 10 million shares outstanding with a float of 5 million (I really like this fundamental). The president and CEO holds a very large position. |
